Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Burden and Disease Characteristics of Patients with Psoriatic Arthritis: A Population-based Cross-sectional Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Real-world drug survival of ixekizumab for psoriasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Skin tape stripping: Which layers of the epidermis are removed?

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Wide-ranging psoriasis prevalence estimates have been reported, possibly due to methodological differences.

OBJECTIVES: To assess the prevalence of psoriasis in Denmark and to validate the use of questionnaire-based data to identify patients with psoriasis.

METHODS: We used data from the Danish Skin Cohort, a prospective cohort comprising general population adults, as well as patients with dermatologist-verified psoriasis and atopic dermatitis, respectively. The general population cohort was interviewed to assess the psoriasis prevalence in Denmark, and validation of the questions was performed.

RESULTS: From 3490 general population participants, 7.9% (n=275) were found to have self-reported psoriasis. Of these, 221 (prevalence 6.3%) had their disease diagnosed by a physician (the dermatologist-diagnosed prevalence was 4.3%), whereas 54 (prevalence 1.6%) were not diagnosed by a physician. A total of 176 (5%) had active psoriasis within the last 12 months. More than half of patients had at least one disease flare in the last 12 months, and 44.4% of patients with psoriasis had at least one family member with psoriasis, whereas this was only the case for 13.7% of non-psoriasis individuals. Validation of the psoriasis diagnosis yielded a high sensitivity and specificity, with little incremental value of limiting diagnoses to those diagnosed by a physician.

CONCLUSION: The lifetime-prevalence of self-reported psoriasis was found to be 7.9%, whereas the 1-year prevalence (ie, currently active psoriasis) was 5.0%. If used appropriately, questionnaire-based data may accurately identify patients with psoriasis.

Original languageEnglish
JournalBMJ Open
Volume9
Issue number3
Pages (from-to)e028116
ISSN2044-6055
DOIs
Publication statusPublished - 20 Mar 2019

ID: 57775058